Patents Assigned to Genexa Inc.
  • Patent number: 12629422
    Abstract: The present invention relates to an aqueous pharmaceutical suspension composition having from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and microcrystalline cellulose; an effective amount of taste masking compositions; and water, as well as a process for producing such aqueous pharmaceutical suspensions.
    Type: Grant
    Filed: April 16, 2024
    Date of Patent: May 19, 2026
    Assignee: GENEXA INC.
    Inventors: Max Spielberg, David Johnson
  • Publication number: 20240415971
    Abstract: A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
    Type: Application
    Filed: March 18, 2024
    Publication date: December 19, 2024
    Applicant: GENEXA INC.
    Inventors: Max Spielberg, David Johnson
  • Publication number: 20240226040
    Abstract: A tablet includes an active material and a base material comprising carnauba wax and an oil. A tablet formulation can contain an active pharmaceutical ingredient and a base material that includes carnauba wax. The carnauba wax constitutes more than 50% of the base material.
    Type: Application
    Filed: March 27, 2024
    Publication date: July 11, 2024
    Applicant: Genexa Inc.
    Inventors: Max Spielberg, David Johnson
  • Patent number: 11617795
    Abstract: A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
    Type: Grant
    Filed: August 4, 2022
    Date of Patent: April 4, 2023
    Assignee: Genexa Inc.
    Inventors: Max Spielberg, David Johnson